These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38892585)

  • 21. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
    Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
    Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine Improved Autism-Like Behaviours and Defective Neurogenesis of the Hippocampus in BTBR Mice through the PTEN/mTOR/AKT Signalling Pathway.
    Xiaoyan H; Zhaoxi Y; Lingli Z; Jinyuan C; Wen Q
    Folia Biol (Praha); 2024; 70(1):45-52. PubMed ID: 38830122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
    Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin Stimulates the SIRT1/Nrf2 Signaling Pathway Counteracting Lipopolysaccharide (LPS)-Induced Oxidative Stress to Rescue Postnatal Rat Brain.
    Shah SA; Khan M; Jo MH; Jo MG; Amin FU; Kim MO
    CNS Neurosci Ther; 2017 Jan; 23(1):33-44. PubMed ID: 27421686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadmium exposure exacerbates immunological abnormalities in a BTBR T
    Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF
    J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
    Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
    Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citalopram attenuates social behavior deficits in the BTBR T
    Cai Y; Wang L; Nalvarte I; Xiao R; Li X; Fan X
    Brain Res Bull; 2019 Aug; 150():75-85. PubMed ID: 31047973
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Park HY; Go J; Ryu YK; Choi DH; Noh JR; An JP; Oh WK; Han PL; Lee CH; Kim KS
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880583
    [No Abstract]   [Full Text] [Related]  

  • 29. The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development.
    Jin Y; Choi J; Won J; Hong Y
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29346266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
    Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM
    Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
    Molenhuis RT; Hutten L; Kas MJH
    Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolving neuroinflammatory and social deficits in ASD model mice: Dexmedetomidine downregulates NF-κB/IL-6 pathway via α2AR.
    Liang ZK; Xiong W; Wang C; Chen L; Zou X; Mai JW; Dong B; Guo C; Xin WJ; Luo DX; Xu T; Feng X
    Brain Behav Immun; 2024 Jul; 119():84-95. PubMed ID: 38552922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic modifications associated with ketogenic diet treatment in the BTBR
    Mychasiuk R; Rho JM
    Autism Res; 2017 Mar; 10(3):456-471. PubMed ID: 27529337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM
    Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism.
    Nuzzo T; Sekine M; Punzo D; Miroballo M; Katane M; Saitoh Y; Galbusera A; Pasqualetti M; Errico F; Gozzi A; Mothet JP; Homma H; Usiello A
    Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140531. PubMed ID: 32853769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin.
    Letra-Vilela R; Sánchez-Sánchez AM; Rocha AM; Martin V; Branco-Santos J; Puente-Moncada N; Santa-Marta M; Outeiro TF; Antolín I; Rodriguez C; Herrera F
    Mol Cell Endocrinol; 2016 Oct; 434():238-49. PubMed ID: 27402602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
    Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
    Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in neuroinflammatory markers and microglial density in the hippocampus and prefrontal cortex of the C58/J mouse model of autism.
    Duarte-Campos JF; Vázquez-Moreno CN; Martínez-Marcial M; Chavarría A; Ramírez-Carreto RJ; Velasco Velázquez MA; De La Fuente-Granada M; González-Arenas A
    Eur J Neurosci; 2024 Jan; 59(1):154-173. PubMed ID: 38057955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.
    Parisotto EB; Vidal V; García-Cerro S; Lantigua S; Wilhelm Filho D; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
    Neurochem Res; 2016 Nov; 41(11):2904-2913. PubMed ID: 27450081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.